About the Company

上海亚盛医药科技有限公司以亚生(上海)医药研发有限公司全部研发团队和研究设施及技术平台重组而成,从事以创新型抗癌药物开发为重点的药品研发、咨询及技术服务及转让。
公司在张江高科技园区拥有1200多平方米的实验室。公司保持小而精的商业模式,采取外包和关键部分内部研发并行的研发策略,具有全球知识产权的*前沿新药开发技术的研发能力。
公司下设药学部、生物学部和临床前研发部。药学部具备药物合成,工艺放大,处方前研究及处方开发,分析化学,GMP和非GMP生产技术转让及外包业务监管功能。生物学部建有肿瘤体外细胞库和肿瘤体内动物模型,从事各种分子药理和药效学试验。临床前研发部与中国顶级的定位于全球的临床前研发机构密切合作,进行药代和毒理研究。按照美国标准建立和培训的研发团队在先导化合物优化,临床候选药物筛选和符合美国FDA和中国SFDA的新药报批等领域有良好的成功纪录,曾参与报批并在30 天内一次性通过美国FDA IND审批。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Financing History (2 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 5亿人民币
  • Investor: 国投创新投资,拾玉资本,元...

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 4,000万(元)
Legal Representative: YANG DAJUN
Date Established:
Credit Code: 91310000MA1K33YM8U
Registered Address: 上海市徐汇区枫林路420号2层A区

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates